Eric I Benchimol1, Douglas G Manuel, Astrid Guttmann, Geoffrey C Nguyen, Nassim Mojaverian, Pauline Quach, David R Mack. 1. *CHEO Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada; †Institute for Clinical Evaluative Sciences, Toronto, ON, Canada; Departments of ‡Pediatrics, §Epidemiology and Community Medicine, and ‖Family Medicine, University of Ottawa, Ottawa, ON, Canada; ¶Ottawa Hospital Research Institute, Ottawa, ON, Canada; **Department of Pediatrics, University of Toronto, Toronto, ON, Canada; ††Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; ‡‡Department of Medicine, University of Toronto, Toronto, ON, Canada; and §§Mount Sinai Centre for Inflammatory Bowel Disease, Toronto, ON, Canada.
Abstract
BACKGROUND: International cohort studies have reported increased incidence of inflammatory bowel disease (IBD) in recent years, and Canada has among the highest rates of IBD in the world. This study assessed incidence and prevalence of IBD in Ontario, the most populous province of Canada, to determine changing trends in age of onset. METHODS: We used a population-based cohort derived from validated health administrative data consisting of all Ontario residents living with IBD from 1999 to 2008. We determined trends over time using Poisson regression analysis, assessing rates in 10-year age groups, children, adults, and the elderly. RESULTS: In 2008, 68,071 people were living with IBD among 12,738,350 people (standardized prevalence 534.3 per 100,000 people). Between 1999 and 2008, standardized IBD incidence increased from 21.3 to 26.2 per 100,000 (2.3% per yr, P < 0.0001). Incidence of Crohn's increased from 9.6 to 12.1 per 100,000 (1.9% per yr, P < 0.0001). Ulcerative colitis incidence increased from 10.7 to 12.1 per 100,000 (2.0% per yr, P < 0.0001). For IBD, incidence increased significantly in people younger than 10 years of age (9.7% per yr, P < 0.0001), 10 to 19 years of age (3.8% per yr, P < 0.0001), 30 to 39 years of age (1.8% per yr, P = 0.0006), 40 to 49 years of age (2.8% per yr, P = 0.0001), and 50 to 59 years of age (2.8% per yr, P < 0.0001). Incidence was stable in patients older than 65 years of age at diagnosis (-0.1% per yr, P = 0.73). Although incidence did not change significantly over time in adults 20 to 29 years, IBD incidence peaked in this age group. CONCLUSIONS: Ontario has among the highest prevalence of IBD in the world. Incidence of IBD increased between 1999 and 2008, owing to increased incidence in children and adults, with stable rates in elderly people. These findings demonstrate the changing age demographics and growing burden of IBD in Ontario, Canada.
BACKGROUND: International cohort studies have reported increased incidence of inflammatory bowel disease (IBD) in recent years, and Canada has among the highest rates of IBD in the world. This study assessed incidence and prevalence of IBD in Ontario, the most populous province of Canada, to determine changing trends in age of onset. METHODS: We used a population-based cohort derived from validated health administrative data consisting of all Ontario residents living with IBD from 1999 to 2008. We determined trends over time using Poisson regression analysis, assessing rates in 10-year age groups, children, adults, and the elderly. RESULTS: In 2008, 68,071 people were living with IBD among 12,738,350 people (standardized prevalence 534.3 per 100,000 people). Between 1999 and 2008, standardized IBD incidence increased from 21.3 to 26.2 per 100,000 (2.3% per yr, P < 0.0001). Incidence of Crohn's increased from 9.6 to 12.1 per 100,000 (1.9% per yr, P < 0.0001). Ulcerative colitis incidence increased from 10.7 to 12.1 per 100,000 (2.0% per yr, P < 0.0001). For IBD, incidence increased significantly in people younger than 10 years of age (9.7% per yr, P < 0.0001), 10 to 19 years of age (3.8% per yr, P < 0.0001), 30 to 39 years of age (1.8% per yr, P = 0.0006), 40 to 49 years of age (2.8% per yr, P = 0.0001), and 50 to 59 years of age (2.8% per yr, P < 0.0001). Incidence was stable in patients older than 65 years of age at diagnosis (-0.1% per yr, P = 0.73). Although incidence did not change significantly over time in adults 20 to 29 years, IBD incidence peaked in this age group. CONCLUSIONS: Ontario has among the highest prevalence of IBD in the world. Incidence of IBD increased between 1999 and 2008, owing to increased incidence in children and adults, with stable rates in elderly people. These findings demonstrate the changing age demographics and growing burden of IBD in Ontario, Canada.
Authors: Eric I Benchimol; Liam Smeeth; Astrid Guttmann; Katie Harron; David Moher; Irene Petersen; Henrik T Sørensen; Jean-Marie Januel; Erik von Elm; Sinéad M Langan Journal: CMAJ Date: 2019-02-25 Impact factor: 8.262
Authors: Silvia Ghione; Hélène Sarter; Mathurin Fumery; Laura Armengol-Debeir; Guillaume Savoye; Delphine Ley; Claire Spyckerelle; Benjamin Pariente; Laurent Peyrin-Biroulet; Dominique Turck; Corinne Gower-Rousseau; J M Andre; M Antonietti; A Aouakli; A Armand; I Aroichane; F Assi; J P Aubet; E Auxenfants; F Ayafi-Ramelot; D Bankovski; B Barbry; N Bardoux; P Baron; A Baudet; B Bazin; A Bebahani; J P Becqwort; V Benet; H Benali; C Benguigui; Ben E Soussan; A Bental; I Berkelmans; J Bernet; K Bernou; C Bernou-Dron; P Bertot; N Bertiaux-Vandaële; V Bertrand; E Billoud; N Biron; B Bismuth; M Bleuet; F Blondel; V Blondin; P Bohon; E Boniface; P Bonnière; E Bonvarlet; P Bonvarlet; A Boruchowicz; R Bostvironnois; M Boualit; B Bouche; C Boudaillez; C Bourgeaux; M Bourgeois; A Bourguet; A Bourienne; J Branche; G Bray; F Brazier; P Breban; H Brihier; V Brung-Lefebvre; P Bulois; P Burgiere; J Butel; J Y Canva; V Canva-Delcambre; J P Capron; F Cardot; P Carpentier; E Cartier; J F Cassar; M Cassagnou; J F Castex; P Catala; S Cattan; S Catteau; B Caujolle; G Cayron; C Chandelier; M Chantre; J Charles; T Charneau; M Chavance-Thelu; D Chirita; A Choteau; J F Claerbout; P Y Clergue; H Coevoet; G Cohen; R Collet; J F Colombel; S Coopman; J Corvisart; A Cortot; F Couttenier; J F Crinquette; V Crombe; I Dadamessi; V Dapvril; T Davion; S Dautreme; J Debas; N Degrave; F Dehont; C Delatre; R Delcenserie; O Delette; T Delgrange; L Delhoustal; J S Delmotte; S Demmane; G Deregnaucourt; P Descombes; J P Desechalliers; P Desmet; P Desreumaux; G Desseaux; P Desurmont; A Devienne; E Devouge; M Devred; A Devroux; A Dewailly; S Dharancy; A Di Fiore; D Djeddi; R Djedir; M L Dreher-Duwat; R Dubois; C Dubuque; P Ducatillon; J Duclay; B Ducrocq; F Ducrot; P Ducrotte; A Dufilho; C Duhamel; D Dujardin; C Dumant-Forest; J L Dupas; F Dupont; Y Duranton; A Duriez; K El Achkar; M El Farisi; C Elie; M C Elie-Legrand; A Elkhaki; M Eoche; D Evrard; J P Evrard; A Fatome; B Filoche; L Finet; M Flahaut; C Flamme; D Foissey; P Fournier; M C Foutrein-Comes; P Foutrein; D Fremond; T Frere; M Fumery; P Gallet; C Gamblin; P S Ganga-Zandzou; R Gérard; G Geslin; Y Gheyssens; N Ghossini; S Ghrib; T Gilbert; B Gillet; D Godard; P Godard; J M Godchaux; R Godchaux; G Goegebeur; O Goria; F Gottrand; P Gower; B Grandmaison; M Groux; C Guedon; J F Guillard; L Guillem; F Guillemot; D Guimber; B Haddouche; S Hakim; D Hanon; V Hautefeuille; P Heckestweiller; G Hecquet; J P Hedde; H Hellal; P E Henneresse; B Heyman; M Heraud; S Herve; P Hochain; L Houssin-Bailly; P Houcke; B Huguenin; S Iobagiu; A Ivanovic; I Iwanicki-Caron; E Janicki; M Jarry; J Jeu; J P Joly; C Jonas; F Katherin; A Kerleveo; A Khachfe; A Kiriakos; J Kiriakos; O Klein; M Kohut; R Kornhauser; D Koutsomanis; J E Laberenne; G Laffineur; M Lagarde; P Lannoy; J Lapchin; M Lapprand; D Laude; R Leblanc; P Lecieux; N Leclerc; C Le Couteulx; J Ledent; J Lefebvre; P Lefiliatre; C Legrand; A Le Grix; P Lelong; B Leluyer; C Lenaerts; L Lepileur; A Leplat; E Lepoutre-Dujardin; H Leroi; M Y Leroy; J P Lesage; X Lesage; J Lesage; I Lescanne-Darchis; J Lescut; D Lescut; B Leurent; P Levy; M Lhermie; A Lion; B Lisambert; F Loire; S Louf; A Louvet; M Luciani; D Lucidarme; J Lugand; O Macaigne; D Maetz; D Maillard; H Mancheron; O Manolache; A B Marks-Brunel; R Marti; F Martin; G Martin; E Marzloff; P Mathurin; J Mauillon; V Maunoury; J L Maupas; B Mesnard; P Metayer; L Methari; B Meurisse; F Meurisse; L Michaud; X Mirmaran; P Modaine; A Monthe; L Morel; P E Mortier; E Moulin; O Mouterde; J Mudry; M Nachury; NʼGuyen E Khac; B Notteghem; V Ollevier; A Ostyn; A Ouraghi; D Ouvry; B Paillot; N Panien-Claudot; C Paoletti; A Papazian; B Parent; B Pariente; J C Paris; P Patrier; L Paupart; B Pauwels; M Pauwels; R Petit; M Piat; S Piotte; C Plane; B Plouvier; E Pollet; P Pommelet; D Pop; C Pordes; G Pouchain; P Prades; A Prevost; J C Prevost; B Quesnel; A M Queuniet; J F Quinton; A Rabache; P Rabelle; G Raclot; S Ratajczyk; D Rault; V Razemon; N Reix; M Revillon; C Richez; P Robinson; J Rodriguez; J Roger; J M Roux; A Rudelli; A Saber; G Savoye; P Schlosseberg; M Segrestin; D Seguy; M Serin; A Seryer; F Sevenet; N Shekh; J Silvie; V Simon; C Spyckerelle; N Talbodec; A Techy; J L Thelu; A Thevenin; H Thiebault; J Thomas; J M Thorel; G Tielman; M Tode; J Toisin; J Tonnel; J Y Touchais; Y Touze; J L Tranvouez; C Triplet; D Turck; S Uhlen; E Vaillant; C Valmage; D Vanco; H Vandamme; E Vanderbecq; Vander E Eecken; P Vandermolen; P Vandevenne; L Vandeville; A Vandewalle; C Vandewalle; P Vaneslander; J P Vanhoove; A Vanrenterghem; P Varlet; I Vasies; G Verbiese; G Vernier-Massouille; P Vermelle; C Verne; P Vezilier-Cocq; B Vigneron; M Vincendet; J Viot; Y M Voiment; A Wacrenier; L Waeghemaecker; J Y Wallez; M Wantiez; F Wartel; J Weber; J L Willocquet; N Wizla; E Wolschies; A Zalar; B Zaouri; A Zellweger; C Ziade Journal: Am J Gastroenterol Date: 2017-08-15 Impact factor: 10.864
Authors: Jordan E Bisanz; Megan K Enos; George PrayGod; Shannon Seney; Jean M Macklaim; Stephanie Chilton; Dana Willner; Rob Knight; Christoph Fusch; Gerhard Fusch; Gregory B Gloor; Jeremy P Burton; Gregor Reid Journal: Appl Environ Microbiol Date: 2015-05-15 Impact factor: 4.792
Authors: Raina Shivashankar; William J Tremaine; W Scott Harmsen; Edward V Loftus Journal: Clin Gastroenterol Hepatol Date: 2016-11-14 Impact factor: 11.382
Authors: Matthew Geisz; Christina Ha; Michael D Kappelman; Christopher F Martin; Wenli Chen; Kristen Anton; Robert S Sandler; Millie D Long Journal: Inflamm Bowel Dis Date: 2016-06 Impact factor: 5.325